The development of new drugs saves lives and so LC believes that clinical trials are a necessity and in many cases an important treatment option for lymphoma patients.
However, between 1997 and 2009, the average number of patients enroled for all clinical trials worldwide per approved FDA drug decreased by 62%.(1)
Although no statistical evidence could be found for lymphomas, it is the general industry consensus of medical and pharmaceutical companies that there has been a decrease in clinical trial enrolment despite an increase in global incidence, as well as an increasing numbers of subtypes. This raises the need even more for patient enrolment in specific clinical trials.
|FOUR PHASES OF CLINICAL TRIALS|
|TRIAL TYPE||MAJOR DIFFERENCES|
Below you will find the Clinical Trials Chart that lists clinical trial website resources by region and country for you to review. Additionally, contact your local patient support organization or your doctor and discuss what options may be available to you.
For further clinical trial information by country or by subtype please visit the global database.
(1) Tufts Center for the Study of Drug Development. http://csdd.tufts.edu, 2009.